Predictors of service disengagement in first-admitted adolescents with psychosis.
Benno Graf Schimmelmann, Philippe Conus, Melanie Schacht...
https://pubmed.ncbi.nlm.nih.gov/16865042/Actively Recruiting
Led by Fundació Sant Joan de Déu · Updated on 2025-05-25
128
Participants Needed
1
Research Sites
67 weeks
Total Duration
Researchers are evaluating the effectiveness of the PIPPEP digital platform in improving treatment adherence and clinical outcomes for young adults aged 18 to 40 who are receiving early intervention for psychosis. This trial aims to assess whether adding the PIPPEP platform to usual care helps patients stick to their psychosocial and pharmacological treatments better. The study also looks at the platforms cost-effectiveness, its reach among patients, and effects on symptoms, medication side effects, social stigma, risk, comorbid symptoms, and social functioning. Participants are randomly assigned to one of two groups. One group receives usual care plus access to the PIPPEP platform, which provides educational content, regular self-assessment questionnaires, two-way messaging with the care team, and gamified rewards. The control group receives usual care without the platform. Questionnaires are completed at the start, six months, and twelve months, with some completed weekly. The intervention program includes multidisciplinary care with psychiatric, nursing, social work, and psychological support for up to five years. Participants will be monitored throughout the study with assessments at baseline, six months, and twelve months. These include adherence to treatment, costs, symptom impact, medication side effects, cognitive insight, substance use, anxiety and depression, social stigma, quality of life, and overall functioning. Data from questionnaires completed via the platform are securely stored in medical records. The study aims to improve engagement and prognosis by combining digital tools with personalized follow-up in early psychosis care.
CONDITIONS
Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme
M
MARIA TRINIDAD PELÁEZ MARTÍNEZ
A
ALICIA COLOMER SALVANS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fundació Sant Joan de Déu
Lead Sponsor
Parc Sanitari Sant Joan de Déu
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants receive multidisciplinary care in the Early Intervention Psychosis Programme. Participants assigned to the experimental group will additionally have access to the PIPPEP digital platform with psychoeducative content, self-completed questionnaires, messaging with the care team, and gamification features to support engagement.
Regular personalised follow-up sessions as part of usual care; questionnaires completed weekly for anxiety and depression, and at baseline, 6 months, and 12 months for other assessments
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Benno Graf Schimmelmann, Philippe Conus, Melanie Schacht...
https://pubmed.ncbi.nlm.nih.gov/16865042/Clare Killikelly, Zhimin He, Clare Reeder...
https://pubmed.ncbi.nlm.nih.gov/28729235/Brynmor Lloyd-Evans, Angela Sweeney, Mark Hinton...
https://pubmed.ncbi.nlm.nih.gov/25934413/Shalini Lal, Ashok Malla
https://pubmed.ncbi.nlm.nih.gov/26454555/C Bonsack, T Pfister, P Conus
https://pubmed.ncbi.nlm.nih.gov/17099591/John Torous, Spencer Roux
https://pubmed.ncbi.nlm.nih.gov/28684386/Amal Abdel-Baki, Shalini Lal, Olivier D-Charron...
https://pubmed.ncbi.nlm.nih.gov/26011657/Daniel Berry, Clancy Blair, Michael Willoughby...
https://pubmed.ncbi.nlm.nih.gov/29720785/Patricia A Areàn, Kien Hoa Ly, Gerhard Andersson
https://pubmed.ncbi.nlm.nih.gov/27489456/C Gay, A Chabaud, E Guilley...
https://pubmed.ncbi.nlm.nih.gov/27053003/Fundació Sant Joan de Déu
Lead Sponsor
Parc Sanitari Sant Joan de Déu
Collaborating Sponsor